Skip to main content
. 2021 Sep 14;13(18):4607. doi: 10.3390/cancers13184607

Figure 4.

Figure 4

USP44 promoter methylation and its correlation to deletions in the genomic region between TMPRSS2 and ERG genes in prostate adenocarcinoma patients. (A) Genome view of the chromosomal region Chr 21 (q22.2-q22.3). (B) Copy number variation data for Chr 21 (q22.2-q22.3) for methHigh and methLow groups. CNV data were obtained by TCGA-PRAD (Firehose Legacy). p values underneath the gene names were calculated with Mann-Whitney test. (C) Oncoprints indicating patients with gene deletion events within the chromosomal region Chr 21 (q22.2-q22.3) in methHigh (left) and methLow (right) group. Gene deletion frequencies (%) within each group are indicated on the right side of the oncoprint. Oncoprints were generated through cbioportal using CNV data from TCGA-PRAD (Firehose Legacy).